Document is current
Any future updates will be listed below
-
Authors
Kerr, Shona M. https://orcid.org/0000-0002-4137-1495
Fletcher, Benjamin S. https://orcid.org/0009-0000-9986-5677
Tzoneva, Gannie https://orcid.org/0000-0001-5784-7796
Shuldiner, Alan R. https://orcid.org/0000-0001-9921-4305
Gilbert, Edmund https://orcid.org/0000-0002-5574-4520
Wilson, James F. https://orcid.org/0000-0001-5751-9178
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MC_UU_00007/10)
Wellcome Trust (222060/Z/20/Z -PIII031)
Haemochromatosis-UK - Fernau Award 2024
- License Information
-
More Information
Article History
Received: 29 January 2025
Accepted: 16 October 2025
First Online: 3 February 2026
Competing interests
: A.R.S. and G.T. are employees and stock and stock option holders of Regeneron Pharmaceuticals, Inc. The remaining authors declare no competing interests.
